Extending the Indications for Full Revascularization with Robotic-Assisted Coronary Artery Bypass
Open Access
- 24 August 2026
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (9) , 411
Abstract
Coronary artery bypass grafting via median sternotomy carries considerable morbidity, and minimally invasive robotic approaches have been increasingly performed for surgical revascularization of coronary arteries. We report our institutional experience in robotic-assisted minimally invasive coronary revascularization in a broad patient population with complex multivessel disease. We retrospectively reviewed robotic-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB) procedures performed at our center between January 2022 and June 2026. Patient demographics, additional procedures and in-hospital outcomes were recorded. A total of 242 patients were included (mean age 63.4 ± 9.7 years; 31 (12.8%) female). Single-vessel bypass was performed in 25 (10.3%) patients; 212 (87.6%) patients underwent an operation on the arrested heart (mean cross-clamp time 66.9 ± 21.7 min) and 15 (6.2%) received an off-pump operation (mean CPB time in on-pump patients 155.7 ± 46.0 min). Full arterial revascularization was achieved in 42 (17.4%) patients; a bilateral internal mammary artery configuration was used in 9 (3.7%) patients. Coronary endarterectomy was performed in 16 (6.6%) patients and concomitant left atrial appendage (LAA) occlusion was performed in three (1.2%) patients. Epiaortic ultrasonography-guided clamp placement was performed in 27 (11.2%) patients with ascending-aortic plaque. In-hospital mortality occurred in two (0.8%) patients; no patient sustained a major neurological deficit, and the transfusion rate was 9.9%. Mean ventilation time was 4.0 (3.0–6.0) hours and mean intensive care unit stay was 22.6 ± 11.2 h. With careful planning and accumulated experience, the indications for robotic-assisted minimally invasive revascularization can be extended to include patients who require full-arterial revascularization, have ascending aortic plaques, complex coronary disease requiring endarterectomy, or atrial fibrillation where concomitant left atrial appendage occlusion is indicated.Keywords
This publication has 30 references indexed in Scilit:
- Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trialThe Lancet, 2026
- The learning curve of robotic cardiac surgery: a scoping reviewJournal of Robotic Surgery, 2025
- Review of minimally invasive coronary artery bypass graftingEuropean Journal of Cardio-Thoracic Surgery, 2025
- The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2024 Update on National Trends and OutcomesThe Annals of Thoracic Surgery, 2025
- Association of Robotic Assistance With Short-term Outcomes After Coronary Artery Bypass GraftingAnnals of Thoracic Surgery Short Reports, 2025
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2024
- Developing Proficiency in Robotic Cardiac SurgeryThe Annals of Thoracic Surgery, 2024
- Minimally invasive cardiac surgeries in 2021: annual report by Japanese society of minimally invasive cardiac surgeryGeneral Thoracic and Cardiovascular Surgery, 2024
- Epiaortic Ultrasound for Assessment of Intraluminal Atheroma; Insights from the REGROUP TrialJournal of Cardiothoracic and Vascular Anesthesia, 2020
- Multivessel Arterial Revascularization via Left Anterior ThoracotomySeminars in Thoracic and Cardiovascular Surgery, 2020